What's new

Human medicines European public assessment report (EPAR): Vyjuvek, beremagene geperpavec, Date of authorisation: 23/04/2025, Status: Authorised

Human medicines European public assessment report (EPAR): Vyjuvek, beremagene geperpavec, Date of authorisation: 23/04/2025, Status: Authorised

May 6, 2025 - 16:29
 0
Human medicines European public assessment report (EPAR): Vyjuvek, beremagene geperpavec, Date of authorisation: 23/04/2025, Status: Authorised
Human medicines European public assessment report (EPAR): Vyjuvek, beremagene geperpavec, Date of authorisation: 23/04/2025, Status: Authorised
Read More

Tags:

Previous Article

PSUSA/00010464/202407

Next Article

Human medicines European public assessment report (EPAR): Herceptin, trastuzumab...

Related Posts

Human medicines European public assessment report (EPAR): Capecitabine Medac, capecitabine, Date of authorisation: 19/11/2012, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR...

May 2, 2025  0

Business process description for regulatory and scienti...

Apr 22, 2025  0

List of eligible industry stakeholder organisations

Apr 29, 2025  0